- Our Story
- Our Methods
- Quality Improvement
- Health Systems Strengthening
- Global Health Security
- Social and Behavior Change Communication
- Research and Evaluation
- HIV and AIDS
- Malaria and Zika
- Maternal, Newborn, and Child Health
- Noncommunicable Diseases
- Reproductive Health and Family Planning
- Vulnerable Children and Families
- Water, Sanitation, and Hygiene
- Our Projects
- Our Resources
- Join Our Team
TB CARE II Launches MDR-TB Fellowship Training Program
The URC-led TB CARE II Project recently launched the Fellowship Training Program (FTP), which is aimed at training health care professionals who encounter multidrug-resistant tuberculosis (MDR-TB). FTP provides in-depth clinical and programmatic knowledge in MDR-TB prevention, treatment, and control. Through this program, TB CARE II hopes to create a cadre of MDR-TB professionals who will contribute to the scale-up of drug-resistant TB programs worldwide.
The first fellowship opportunity is in Tomsk, Russia, from May 7 through June 1, 2012. Partners In Health (PIH), a global leader in the treatment of MDR-TB, will run the intensive four-week training program, which will include supervised clinical and/or field experience with PIH clinical staff and Tomsk TB physicians.
The program is accepting applications for the Russia fellowship through March 1, 2012. Applicants should have a degree in medicine, a minimum of three years' experience working in TB control services, an understanding of the basics of public health and TB program management, and an ability to speak and understand Russian. Fellows will receive a round-trip, economy-class plane ticket as well as a stipend to cover living expenses and meals.
FTP is funded under TB CARE II through the U.S. Agency for International Development (USAID). TB CARE II provides global leadership and support to national TB programs and other in-country partners to scale up evidence-based interventions and improve outcomes in TB prevention and control.
Fellowships in Lesotho and Peru will become available later this year. For more information, please visit the TB CARE II website.
January 30, 2012